{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:45:02Z","timestamp":1790203502584,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.trim.2013.05.004","type":"journal-article","created":{"date-parts":[[2013,5,15]],"date-time":"2013-05-15T04:49:22Z","timestamp":1368593362000},"page":"145-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Severe antibody-mediated rejection following IVIG infusion in a kidney transplant recipient with BK-virus nephropathy"],"prefix":"10.1016","volume":"28","author":[{"given":"R.","family":"Mainra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Chibbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Shoker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2013.05.004_bb0005","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1600-6143.2010.03400.x","article-title":"Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients","volume":"11","author":"Jordan","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trim.2013.05.004_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/TP.0b013e3181a9e89a","article-title":"Intravenous immunoglobulin a natural regulator of immunity and inflammation","volume":"88","author":"Jordan","year":"2009","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.trim.2013.05.004_bb0015","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1586\/eci.11.10","article-title":"Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation","volume":"7","author":"Jordan","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.trim.2013.05.004_bb0020","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1034\/j.1600-6143.2003.00121.x","article-title":"Utility of intravenous immune globulin in kidney transplantation: efficacy, safety, and cost implications","volume":"3","author":"Jordan","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trim.2013.05.004_bb0025","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.tp.0000181096.14257.c2","article-title":"Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipients","volume":"81","author":"Sener","year":"2006","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.trim.2013.05.004_bb0095","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1111\/j.1399-3046.2010.01384.x","article-title":"Intravenous immunoglobulin therapy in the treatment of BK viremia and nephropathy in pediatric renal transplant recipients","volume":"16","author":"Anyaegbu","year":"2012","journal-title":"Pediatr Transplant [Internet]"},{"issue":"1","key":"10.1016\/j.trim.2013.05.004_bb0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1023\/A:1027380210989","article-title":"Multicenter crossover comparison of the safety and efficacy of Intraglobin-F with Gamimune-N, Sandoglobulin, and Gammagard in patients with primary immunodeficiency diseases","volume":"17","author":"Schiff","year":"1997","journal-title":"J Clin Immunol [Internet]"},{"issue":"null","key":"10.1016\/j.trim.2013.05.004_bb0105","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.humimm.2011.07.118","article-title":"93-P analysis of HLA antibody titer and C1q binding capability in Privigen and Carimune IVIG preparations","volume":"72","author":"Lomago","year":"2011","journal-title":"Hum Immunol [Internet]"},{"key":"10.1016\/j.trim.2013.05.004_bb0045","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ki.1993.259","article-title":"International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology","volume":"44","author":"Solez","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.trim.2013.05.004_bb0050","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1034\/j.1600-6143.2003.00072.x","article-title":"Antibody-mediated rejection criteria \u2014 an addition to the Banff 097 classification of renal allograft rejection","volume":"3","author":"Racusena","year":"2003","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.trim.2013.05.004_bb0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.5414\/CNP75271","article-title":"C4d-negative antibody-mediated rejection in renal allografts: evidence for its existence and effect on graft survival","volume":"75","author":"Haas","year":"2011","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.trim.2013.05.004_bb0060","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1600-6143.2011.03926.x","article-title":"Banff 2011 meeting report: new concepts in antibody-mediated rejection","volume":"12","author":"Mengel","year":"2012","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.trim.2013.05.004_bb0110","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1111\/j.1600-6143.2009.02800.x","article-title":"De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure","volume":"9","author":"Hidalgo","year":"2009","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg [Internet]"},{"issue":"12","key":"10.1016\/j.trim.2013.05.004_bb0115","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1097\/01.ASN.0000145878.92906.9F","article-title":"Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial","volume":"15","author":"Jordan","year":"2004","journal-title":"J Am Soc Nephrol JASN [Internet]"},{"key":"10.1016\/j.trim.2013.05.004_bb0075","doi-asserted-by":"crossref","first-page":"844","DOI":"10.2215\/CJN.01701105","article-title":"Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experience","volume":"1","author":"Vo","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.trim.2013.05.004_bb0080","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2215\/CJN.00500108","article-title":"High-dosage intravenous immunoglobulin-associated macrovacuoles are associated with chronic tubulointerstitial lesion worsening in renal transplant recipients","volume":"3","author":"Boll\u00e9e","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.trim.2013.05.004_bb0085","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1345\/aph.1H434","article-title":"Proposed relationship between intravenous immunoglobulin and thrombosis in renal transplant recipients","volume":"41","author":"Duronio","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.trim.2013.05.004_bb0090","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.2215\/CJN.04540709","article-title":"Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly HLA sensitized patients","volume":"4","author":"Kahwaji","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.trim.2013.05.004_bb0120","series-title":"American Association of Blood Banks Bulletin #06-07","first-page":"1","author":"Strong","year":"2006"}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327413000373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327413000373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T01:00:39Z","timestamp":1539651639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327413000373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0966327413000373"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2013.05.004","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe antibody-mediated rejection following IVIG infusion in a kidney transplant recipient with BK-virus nephropathy","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2013.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}